Trials in New Hampshire.
9 APOE4-relevant Alzheimer’s trials run in New Hampshire — 2 of them recruiting. Each one translated into plain English, with our read on what it means for an APOE4 carrier.
- Where
- Lebanon · Portsmouth · Dover
- Recruiting
- 2 of 9
Non-carriers only, not for APOE4
Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)This trial tested bapineuzumab, an infused antibody designed to bind and clear beta amyloid from the brain, against a placebo. It measured whether it helped…
CompletedPhase 3NCT00574132Drug trial for symptomatic early Alzheimer's
A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)This trial tests sabirnetug, an antibody given by IV infusion every four weeks, against placebo. It looks at whether the drug slows decline in thinking and…
ActivePhase 2NCT06335173Enrolled carriers, prior data unfavorable
Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's DiseaseThis trial tested whether rosiglitazone extended release, a diabetes drug, could improve thinking and memory in people already taking donepezil for mild to…
CompletedObservationalNCT00348309Not APOE4-related, movement disorder focus
Trial of Parkinson's And Zoledronic AcidThis trial is testing whether a single IV infusion of zoledronic acid, a bone-strengthening drug already approved for osteoporosis, can reduce fractures in…
CompletedPhase 4NCT03924414Imaging study, end-of-life patients only
[18F]PI-2620 Phase 3 Histopathological StudyThis trial tests a brain scan, not a treatment. A tracer called PI-2620 is given before a PET scan to show tau, a protein tied to Alzheimer's. Researchers…
RecruitingPhase 3NCT05641688Observational only, genotype not considered
MCI Speech in NoiseThis study is testing whether people with mild cognitive impairment (MCI) process sound differently than people with normal cognition. Researchers are…
RecruitingNCT06102486Open to carriers, not 4-specific
Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's DiseaseThis Phase 2 trial is testing BMS-986446, an antibody designed to target a specific form of tau protein that builds up in Alzheimer's disease. Researchers want…
ActivePhase 2NCT06268886Unrelated to APOE4 or dementia
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)This Phase 3 trial is testing povorcitinib, a JAK inhibitor pill, against a placebo in people with prurigo nodularis — a chronic skin condition causing intense…
ActivePhase 3NCT06516965Not genotype related, care planning only
Advancing Ethical Goals In Society TrialThis trial tests a video and counselor based Advance Care Planning program for older adults with dementia or high mortality risk. It measures whether the…
Not yet recruitingObservationalNCT07824245
Copy a forum-ready post
Keep exploring
Educational, not medical advice. Trial decisions belong between you and your physician.